CSE:AGN - Post Discussion
Post by
C10H12N2 on Jan 27, 2023 3:37pm
All Roads Lead To Dante's Inferno @ Algernon Pharmaceuticals
Take a look at the performance of Xortx Therapeutics (XRTX) today with its recent move towards a Phase III clinical trial. They're now at 52 week low with no bottom. The relevance is Xortx's recently resigned CEO is the sole member of Algernon Pharmaceuticals "Business Advisory Board". Business Advisory Board - Algernon Pharmaceuticals
Be the first to comment on this post